Chemotherapy use and associated factors among cancer patients near the end of life

Young Ho Yun, Miyoung Kwak, Sang Min Park, Samyong Kim, Jong Soo Choi, Ho Yeong Lim, Chang Geol Lee, Youn Seon Choi, Young Seon Hong, Si Young Kim, Dae Seog Heo

Research output: Contribution to journalArticle

48 Citations (Scopus)

Abstract

Objectives: We investigated the frequency of chemotherapy use and its associated factors in patients in all age groups in the last year of life. Methods: We identified cancer patients who died in 2004 in any of 17 hospitals. We used demographic and treatment characteristics by computerized hospital information systems and by linking the identification numbers to the 2004 death registry. Results: 48.7% of patients in the last 6 months of life, 43.9% in the last 3 months, and 30.9% in the last month of life received chemotherapy. The frequency of chemotherapy use was lower for older patients. In those ≥65 years old, there was no difference between women and men in the proportion that received chemotherapy. For patients <65 years of age, a larger proportion of women than men received chemotherapy, and chemotherapy use was significantly less frequent for patients with refractory disease than for those with responsive disease. Patients dying at a relatively small hospital without a hospice inpatient unit were significantly more likely to receive chemotherapy. Conclusions: Despite the fact that most cancer patients are resistant to chemotherapy at the end of life, it was administered often to all age groups.

Original languageEnglish
Pages (from-to)164-171
Number of pages8
JournalOncology
Volume72
Issue number3-4
DOIs
Publication statusPublished - 2008 Jan 1

Fingerprint

Drug Therapy
Age Groups
Hospital Information Systems
Hospices
neoplasm-associated factor
Registries
Inpatients
Neoplasms
Demography
Therapeutics

Keywords

  • Chemotherapy
  • Chemotherapy, end of life

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Cite this

Yun, Y. H., Kwak, M., Park, S. M., Kim, S., Choi, J. S., Lim, H. Y., ... Heo, D. S. (2008). Chemotherapy use and associated factors among cancer patients near the end of life. Oncology, 72(3-4), 164-171. https://doi.org/10.1159/000112802

Chemotherapy use and associated factors among cancer patients near the end of life. / Yun, Young Ho; Kwak, Miyoung; Park, Sang Min; Kim, Samyong; Choi, Jong Soo; Lim, Ho Yeong; Lee, Chang Geol; Choi, Youn Seon; Hong, Young Seon; Kim, Si Young; Heo, Dae Seog.

In: Oncology, Vol. 72, No. 3-4, 01.01.2008, p. 164-171.

Research output: Contribution to journalArticle

Yun, YH, Kwak, M, Park, SM, Kim, S, Choi, JS, Lim, HY, Lee, CG, Choi, YS, Hong, YS, Kim, SY & Heo, DS 2008, 'Chemotherapy use and associated factors among cancer patients near the end of life', Oncology, vol. 72, no. 3-4, pp. 164-171. https://doi.org/10.1159/000112802
Yun YH, Kwak M, Park SM, Kim S, Choi JS, Lim HY et al. Chemotherapy use and associated factors among cancer patients near the end of life. Oncology. 2008 Jan 1;72(3-4):164-171. https://doi.org/10.1159/000112802
Yun, Young Ho ; Kwak, Miyoung ; Park, Sang Min ; Kim, Samyong ; Choi, Jong Soo ; Lim, Ho Yeong ; Lee, Chang Geol ; Choi, Youn Seon ; Hong, Young Seon ; Kim, Si Young ; Heo, Dae Seog. / Chemotherapy use and associated factors among cancer patients near the end of life. In: Oncology. 2008 ; Vol. 72, No. 3-4. pp. 164-171.
@article{10f8cfaa623a4b21872b51a13dc93885,
title = "Chemotherapy use and associated factors among cancer patients near the end of life",
abstract = "Objectives: We investigated the frequency of chemotherapy use and its associated factors in patients in all age groups in the last year of life. Methods: We identified cancer patients who died in 2004 in any of 17 hospitals. We used demographic and treatment characteristics by computerized hospital information systems and by linking the identification numbers to the 2004 death registry. Results: 48.7{\%} of patients in the last 6 months of life, 43.9{\%} in the last 3 months, and 30.9{\%} in the last month of life received chemotherapy. The frequency of chemotherapy use was lower for older patients. In those ≥65 years old, there was no difference between women and men in the proportion that received chemotherapy. For patients <65 years of age, a larger proportion of women than men received chemotherapy, and chemotherapy use was significantly less frequent for patients with refractory disease than for those with responsive disease. Patients dying at a relatively small hospital without a hospice inpatient unit were significantly more likely to receive chemotherapy. Conclusions: Despite the fact that most cancer patients are resistant to chemotherapy at the end of life, it was administered often to all age groups.",
keywords = "Chemotherapy, Chemotherapy, end of life",
author = "Yun, {Young Ho} and Miyoung Kwak and Park, {Sang Min} and Samyong Kim and Choi, {Jong Soo} and Lim, {Ho Yeong} and Lee, {Chang Geol} and Choi, {Youn Seon} and Hong, {Young Seon} and Kim, {Si Young} and Heo, {Dae Seog}",
year = "2008",
month = "1",
day = "1",
doi = "10.1159/000112802",
language = "English",
volume = "72",
pages = "164--171",
journal = "Oncology",
issn = "0030-2414",
publisher = "UBM Medica Healthcare Publications",
number = "3-4",

}

TY - JOUR

T1 - Chemotherapy use and associated factors among cancer patients near the end of life

AU - Yun, Young Ho

AU - Kwak, Miyoung

AU - Park, Sang Min

AU - Kim, Samyong

AU - Choi, Jong Soo

AU - Lim, Ho Yeong

AU - Lee, Chang Geol

AU - Choi, Youn Seon

AU - Hong, Young Seon

AU - Kim, Si Young

AU - Heo, Dae Seog

PY - 2008/1/1

Y1 - 2008/1/1

N2 - Objectives: We investigated the frequency of chemotherapy use and its associated factors in patients in all age groups in the last year of life. Methods: We identified cancer patients who died in 2004 in any of 17 hospitals. We used demographic and treatment characteristics by computerized hospital information systems and by linking the identification numbers to the 2004 death registry. Results: 48.7% of patients in the last 6 months of life, 43.9% in the last 3 months, and 30.9% in the last month of life received chemotherapy. The frequency of chemotherapy use was lower for older patients. In those ≥65 years old, there was no difference between women and men in the proportion that received chemotherapy. For patients <65 years of age, a larger proportion of women than men received chemotherapy, and chemotherapy use was significantly less frequent for patients with refractory disease than for those with responsive disease. Patients dying at a relatively small hospital without a hospice inpatient unit were significantly more likely to receive chemotherapy. Conclusions: Despite the fact that most cancer patients are resistant to chemotherapy at the end of life, it was administered often to all age groups.

AB - Objectives: We investigated the frequency of chemotherapy use and its associated factors in patients in all age groups in the last year of life. Methods: We identified cancer patients who died in 2004 in any of 17 hospitals. We used demographic and treatment characteristics by computerized hospital information systems and by linking the identification numbers to the 2004 death registry. Results: 48.7% of patients in the last 6 months of life, 43.9% in the last 3 months, and 30.9% in the last month of life received chemotherapy. The frequency of chemotherapy use was lower for older patients. In those ≥65 years old, there was no difference between women and men in the proportion that received chemotherapy. For patients <65 years of age, a larger proportion of women than men received chemotherapy, and chemotherapy use was significantly less frequent for patients with refractory disease than for those with responsive disease. Patients dying at a relatively small hospital without a hospice inpatient unit were significantly more likely to receive chemotherapy. Conclusions: Despite the fact that most cancer patients are resistant to chemotherapy at the end of life, it was administered often to all age groups.

KW - Chemotherapy

KW - Chemotherapy, end of life

UR - http://www.scopus.com/inward/record.url?scp=38549140157&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=38549140157&partnerID=8YFLogxK

U2 - 10.1159/000112802

DO - 10.1159/000112802

M3 - Article

VL - 72

SP - 164

EP - 171

JO - Oncology

JF - Oncology

SN - 0030-2414

IS - 3-4

ER -